211 related articles for article (PubMed ID: 37915135)
1. Regulation of CMGC kinases by hypoxia.
Kim K; Lee SB
BMB Rep; 2023 Nov; 56(11):584-593. PubMed ID: 37915135
[TBL] [Abstract][Full Text] [Related]
2. Proline Hydroxylation Primes Protein Kinases for Autophosphorylation and Activation.
Lee SB; Ko A; Oh YT; Shi P; D'Angelo F; Frangaj B; Koller A; Chen EI; Cardozo T; Iavarone A; Lasorella A
Mol Cell; 2020 Aug; 79(3):376-389.e8. PubMed ID: 32640193
[TBL] [Abstract][Full Text] [Related]
3. Alternative regulation of HIF-1α stability through Phosphorylation on Ser451.
Han HJ; Saeidi S; Kim SJ; Piao JY; Lim S; Guillen-Quispe YN; Choi BY; Surh YJ
Biochem Biophys Res Commun; 2021 Mar; 545():150-156. PubMed ID: 33550096
[TBL] [Abstract][Full Text] [Related]
4. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
5. Implications of Oxygen Homeostasis for Tumor Biology and Treatment.
Garvalov BK; Acker T
Adv Exp Med Biol; 2016; 903():169-85. PubMed ID: 27343096
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
7. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
8. CMGC Kinases in Health and Cancer.
Chowdhury I; Dashi G; Keskitalo S
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568654
[TBL] [Abstract][Full Text] [Related]
9. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression.
Satija S; Kaur H; Tambuwala MM; Sharma P; Vyas M; Khurana N; Sharma N; Bakshi HA; Charbe NB; Zacconi FC; Aljabali AA; Nammi S; Dureja H; Singh TG; Gupta G; Dhanjal DS; Dua K; Chellappan DK; Mehta M
Curr Mol Pharmacol; 2021; 14(3):321-332. PubMed ID: 33494692
[TBL] [Abstract][Full Text] [Related]
11. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.
Yasuda H
Nitric Oxide; 2008 Sep; 19(2):205-16. PubMed ID: 18503779
[TBL] [Abstract][Full Text] [Related]
12. A Key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in Tumor cells.
Meyuhas R; Pikarsky E; Tavor E; Klar A; Abramovitch R; Hochman J; Lago TG; Honigman A
Mol Cancer Res; 2008 Sep; 6(9):1397-409. PubMed ID: 18819928
[TBL] [Abstract][Full Text] [Related]
13. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications.
Brahimi-Horn C; Mazure N; Pouysségur J
Cell Signal; 2005 Jan; 17(1):1-9. PubMed ID: 15451019
[TBL] [Abstract][Full Text] [Related]
14. Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets.
Dimova EY; Michiels C; Kietzmann T
Curr Pharm Des; 2009; 15(33):3867-77. PubMed ID: 19671044
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia accelerates the progression of angiosarcoma through the regulation of angiosarcoma cells and tumor microenvironment.
Maeda-Otsuka S; Kajihara I; Tasaki Y; Yamada-Kanazawa S; Sakamoto R; Sawamura S; Masuzawa M; Masuzawa M; Amoh Y; Hoshina D; Abe R; Komohara Y; Ihn H
J Dermatol Sci; 2019 Feb; 93(2):123-132. PubMed ID: 30704938
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia.
Oh ET; Kim CW; Kim SJ; Lee JS; Hong SS; Park HJ
Sci Rep; 2016 Jun; 6():27382. PubMed ID: 27263528
[TBL] [Abstract][Full Text] [Related]
17. Feedback regulators of hypoxia-inducible factors and their role in cancer biology.
Henze AT; Acker T
Cell Cycle; 2010 Jul; 9(14):2749-63. PubMed ID: 20603601
[TBL] [Abstract][Full Text] [Related]
18. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
19. Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells.
Um JH; Kang CD; Bae JH; Shin GG; Kim DW; Kim DW; Chung BS; Kim SH
Exp Mol Med; 2004 Jun; 36(3):233-42. PubMed ID: 15272235
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
